Svastia
Svastia (Svastia Genetics Inc.) is a precision-genomics and oncology data company that bundles clinical research products with cutting-edge bioinformatics to accelerate precision cancer therapy. It offers DNA/RNA sequencing, exome and gene-panel assays, immune (B/T-cell) repertoire sequencing, cell-based drug-efficacy screening, therapeutic-antibody development toolkits, and siRNA design, together with biomarker analytics (Tumor Mutational Burden, Microsatellite Instability) and clinical reporting based on ACMG/ASCO guidelines. Svastia serves hospitals, diagnostics labs, researchers, and CROs, and runs a bespoke clinical/genetic data-collection service across a hospital network, with HL7-FHIR data exchange between EHR and Clinical Trial Management Systems. Products are delivered through a login-gated web portal; the company does not publish a public developer API. Backed by 500 Global; offices in San Francisco (USA) and Cambridge (UK).
Svastia is profiled on the APIs.io network. Tagged areas include Company, Genomics, Oncology, Precision Medicine, and Bioinformatics.
Svastia’s developer surface includes support and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API